INVESTIGATING S100A4 AS THERAPEUTIC TARGET VIS-À-VIS EMPLOYABILITY OF AYURVEDIC CONCEPTS FOR ADVANCED RESEARCH AND CLINICAL RELEVANCE Vivek Sharma Scientist In-charge Division of Cancer Research Department of Biotechnology Chandigarh Group of Colleges, Mohali & Founder, Anvaya Biosciences (a start-up company) Ph. No. +91-8054 66 7211; E-mail: [email protected]
21
Embed
INVESTIGATING S100A4 AS THERAPEUTIC TARGET VIS-À-VIS EMPLOYABILITY OF AYURVEDIC CONCEPTS FOR ADVANCED RESEARCH AND CLINICAL RELEVANCE Vivek Sharma Scientist.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
INVESTIGATING S100A4 AS THERAPEUTIC TARGET VIS-À-VIS
EMPLOYABILITY OF AYURVEDIC CONCEPTS FOR ADVANCED RESEARCH AND CLINICAL RELEVANCE
Vivek SharmaScientist In-chargeDivision of Cancer ResearchDepartment of BiotechnologyChandigarh Group of Colleges, Mohali &
Fig. (1a) Distances between active site residues of 3C1V and Fenugreekine in Angstrom (Å)
Fig. (1b) Fitting of Fenugreekine in the active site cavity of 3C1V.
INTERACTION BETWEEN GERANIOL AND 3C1V
GERANIOL
Fig. 2: Fitting of Geraniol in the active site cavity of 3C1V.
SIMULATION STUDIES
Fig. 3: Simulation studies and comparison of potential energies and temperature parameters between (a) 3C1V, (b) 3C1V-Fenugreekine and (c) 3C1V-Geraniol complex.
a
ba
b c
c
QUESTION IN FOCUS!
In the current day clinical practice, what treatment strategy is adopted to treat a patient with metastasis?
Best answer one can get is combinatorial therapies. Looking at new targetsNew mutationsFinding out new molecules
THE TRANSLATIONAL SIGNIFICANCE!
Yes they are.
But, how much comprehensively these therapies are
applicable?
What is the success rate?
Are these therapies treating the disease or just managing it?
Are the fields of genomics, proteomics and metabolomics really
helping us in finding out the therapies for diseases?
Are the processes of pre-clinical trials, clinical trials (Phase I, II,
III) and the pharmacovigilance robust enough?
SYSTEMS APPROACH
MAJOR ELEMENTS AND REQUIREMENTS OF SYSTEMS BIOLOGYMolina F et al. (2010)
AYURVEDA
Ayurveda is Upveda of ‘Athraveda’ and its practice can
be traced back to 3000 BCE.
Is the oldest system of medicine known in the world
with reported evidences by the sages and saints of
ancient India.
It deals with the holistic understanding of the disease,
followed by holistic treatment.
BASIC PRINCIPLES OF AYURVEDA
Principle of Tridosha – Vata, Pitta, Kapha Principle of Panchmahabhutas – Akash (Space), Vayu (Air),
Jal (Water), Agni (Fire), Prithvi (Earth) Principle of Saptdhatu – Rasa (Plasma), Rakta (blood cells),
Principle of Srotvijanana – which is about Macrocosm – microcosm continuum and it correlates with Quantum Biology concept.
Discipline of Bhaisjya Kalpana – field of Drug delivery in Ayurveda
INTEGRATING THE KNOWLEDGE!
Can we integrate the knowledge of Ayurveda with the tools of genomics and proteomics to build a platform which can be used for development of truly integrative and personalized medicine?
Can we bring in the original principles of Ayurveda in modern day research models?
REPORTS
HOW CAN WE DO IT?
INTEGRATING THE SCIENCE OF AYURVEDA WITH MODERN TECHNOLOGIES
To create a amalgamated platform for bringing together the molecular diagnostics, Ayurveda diagnostics and treatment strategies from both fields with personalized approach.
To create a library of plant based compounds and there derivatives having potential therapeutic effect in cancer (for example).
To create awareness among Ayurveda fraternity for importance of molecular tools and techniques and how these tools can be helpful in validating the ancient knowledge for its global acceptance.
ACKNOWLEDGEMENTS Prof. (Dr.) Upendra K. Jain, Director – Principal,
Chandigarh College of Pharmacy, CGC, Mohali. Mrs. Palki Sahib Kaur, HOD – Dept. of Biotechnology,
CGC, Mohali. Collaborators:
Mr. Rakesh Kr. Pandit, Assistant Professor, Bioinformatics, Dept. of Biotechnology, CGC.
Mrs. Piyusha Sharma, Anvaya Biosciences Mr. Aniket Sinha, Anvaya Biosciences